Editorial: clinical outcomes in lean <scp>NAFLD</scp>—the devil is in the details-Reference-Cited by-同舟云学术

Editorial: clinical outcomes in lean NAFLD—the devil is in the details

Published:2023-04-13 Issue:9 Volume:57 Page:1040-1041
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Tan Eunice X. X.¹^ORCID,Muthiah Mark Dhinesh¹^ORCID,Ng Cheng Han¹^ORCID,Huang Daniel Q.¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine National University of Singapore Singapore Singapore

Abstract

LINKED CONTENTThis article is linked to Wijarnpreecha et al papers. To view these articles, visit https://doi.org/10.1111/apt.17424 and https://doi.org/10.1111/apt.17453

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17449

Reference10 articles.

1. Global incidence and prevalence of nonalcoholic fatty liver disease

2. Non-alcoholic fatty liver disease

3. Shared Mechanisms between Cardiovascular Disease and NAFLD

4. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH

5. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review;Translational Gastroenterology and Hepatology;2024-01

2. Normal weight and central obesity as predictors of increased all-cause mortality in metabolic dysfunction associated steatotic liver disease;Journal of Hepatology;2023-12

3. Editorial: clinical outcomes in lean NAFLD – the devil is in the details. Authors' reply;Alimentary Pharmacology & Therapeutics;2023-04-13